The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cerebrospinal fluid circulating tumor cells (CSF CTC) for real-time patient monitoring and response to treatment.
 
Rachna Malani
No Relationships to Disclose
 
Martin Fleisher
No Relationships to Disclose
 
Xuling Lin
No Relationships to Disclose
 
Antonio Marcilio Padula Omuro
Consulting or Advisory Role - Alexion Pharmaceuticals; AstraZeneca; Bristol-Myers Squibb; Inovio Pharmaceuticals; Juno Therapeutics; Merck; Oxigene; Stemline Therapeutics
 
Morris D. Groves
Employment - Texas Oncology
Stock and Other Ownership Interests - Agios; Biogen; Epizyme; Galectin Therapeutics; Gilead Sciences; illumina; Karyopharm Therapeutics; Ocata Therapeutics; Pharmacyclics; Synageva Biopharma; Synta; Teva; Valeant Pharmaceuticals International
Honoraria - CytRx Corporation; Foundation Medicine
Consulting or Advisory Role - CytRx Corporation; Foundation Medicine; Incyte; Novocure
Speakers' Bureau - Foundation Medicine; Novocure
Travel, Accommodations, Expenses - CytRx Corporation; Foundation Medicine
 
Nancy U. Lin
Consulting or Advisory Role - Novartis
Research Funding - Array BioPharma; Genentech; GlaxoSmithKline; Kadmon; Novartis; Oncothyreon
 
Michelle E. Melisko
Stock and Other Ownership Interests - Merrimack (I)
Honoraria - Agendia; Genentech; Genentech (I); Nektar; Pfizer (I)
Consulting or Advisory Role - Genentech (I)
Speakers' Bureau - Agendia; Genentech (I); Pfizer (I)
Research Funding - Celldex (Inst); Galena Biopharma (Inst); Genentech (Inst); Lilly (Inst); Puma Biotechnology (Inst)
Patents, Royalties, Other Intellectual Property - Multiple patents related to immunoliposomal drugs being studied and potentially brought to market by Merrimack (I)
 
Andrew B. Lassman
Honoraria - Prime Oncology
Consulting or Advisory Role - Abbvie; AstraZeneca; BioClinica; Cortice Biosciences; Genentech/Roche; Novartis; Novocure; Oxigene; Regeneron; SapVax; VBI Vaccines
Research Funding - Abbvie (Inst); Aeterna Zentaris (Inst); Agenus (Inst); Amgen (Inst); Bayer/Onyx (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); e-Therapeutics (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); ImmunoCellular Therapeutics (Inst); Kadmon (Inst); Karyopharm Therapeutics (Inst); MedImmune (Inst); Merck (Inst); Millennium (Inst); Northwest Biotherapeutics (Inst); Novartis (Inst); Novocure (Inst); Novocure (Inst); Pfizer (Inst); Plexxikon (Inst); Regeneron (Inst); Stemline Therapeutics (Inst); Tocagen (Inst); VBL Therapeutics (Inst)
 
Suriya A. Jeyapalan
No Relationships to Disclose
 
Samuel Briggs
No Relationships to Disclose
 
Lisa Marie DeAngelis
Consulting or Advisory Role - BMJ publishing; CarThera; Juno Therapeutics; Roche; SapVax
 
Jeffrey J. Raizer
Employment - Agenus
Stock and Other Ownership Interests - Agenus; Cancer Action Now; Exicure
Honoraria - Bristol-Myers Squibb; Cortice; CytRx Corporation; Genentech/Roche; Novocure
Consulting or Advisory Role - Bristol-Myers Squibb; Cortice; CytRx Corporation; Genentech/Roche; Novocure
Speakers' Bureau - Genentech/Roche; Novocure
Research Funding - Genentech/Roche; Merck; Novartis; Plexxikon; Stemline Therapeutics
 
Elena Pentsova
No Relationships to Disclose